Daclatasvir, sofosbuvir with or without ribavirin for 24 weeks in hepatitis C genotype 3 cirrhosis: A real-life study.
Authors: lionetti R
Date: May 2019
Scope of interest: infectious/hepatological
Authors: lionetti R
Date: May 2019
Scope of interest: infectious/hepatological
Authors: Daniela Nasso,Silvia Bolis, Elisabetta Abbruzzese, Ilaria Romano,Ida Provenzano Cristiano Tesei,Ida Provenzano, Maria Cantonetti
Date: 2020
Scope of interest: Haematology
Authors: Giuli C, Smoke Scavenger L, Sirolla C, Abbatecola AM, Lattanzio F, Postacchini D
Date: 2012
Scope of interest: ageing
Authors: M. Fanella, A. Morano, J. Fattouch, S. Casciato, M. Albini, L.M. Basili, M. Frascarelli, T. Accinni, A. Buzzanca, A.T. Giallonardo, M. Biondi, F. Di Fabio, C. Di Bonaventura
Date: 2018
Scope of interest: Rare diseases/epilepsy
Click on the icon of the service you are looking for and go to the dedicated section. If the service is not in the selection, go to Service Guide